This study tested an experimental vaccine called INO-4700 designed to protect against Middle East Respiratory Syndrome (MERS). Researchers enrolled 192 healthy volunteers to check if the vaccine was safe and if it triggered an immune response. The vaccine was given as a skin inje…
Phase: PHASE2 • Sponsor: Inovio Pharmaceuticals • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:34 UTC